These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8501181)

  • 61. Shrinkage effect of gonadotropin releasing hormone agonist treatment on uterine leiomyomas and t(12;14).
    Takahashi K; Kawamura N; Ishiko O; Ogita S
    Int J Oncol; 2002 Feb; 20(2):279-83. PubMed ID: 11788889
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [GnRH analogues and myomas: against but...].
    Fernandez H
    Gynecol Obstet Fertil; 2005 Dec; 33(12):1019-22. PubMed ID: 16314135
    [No Abstract]   [Full Text] [Related]  

  • 63. Experience with leuprorelin acetate depot in the treatment of fibroids: a German multicentre study.
    Cirkel U; Ochs H; Schneider HP; Mettler L; Mayer-Eichberger D; Schindler AE; Bühler K; Winkler U; Zahradnik HP; Künzig HJ
    Clin Ther; 1992; 14 Suppl A():37-50. PubMed ID: 1606593
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Fibroma: surgical myomectomy or embolization or GnRH analogs? Intramural and sub-serous fibroma: start with medical treatment!].
    Cohen J
    Gynecol Obstet Fertil; 2001 Jan; 29(1):64-6. PubMed ID: 11217196
    [No Abstract]   [Full Text] [Related]  

  • 65. Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix.
    Gonzalez-Barcena D; Alvarez RB; Ochoa EP; Cornejo IC; Comaru-Schally AM; Schally AV; Engel J; Reissmann T; Riethmüller-Winzen H
    Hum Reprod; 1997 Sep; 12(9):2028-35. PubMed ID: 9363724
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones.
    Malik M; Britten J; Cox J; Patel A; Catherino WH
    Fertil Steril; 2016 Jan; 105(1):214-24. PubMed ID: 26409322
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
    Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Leukopenia induced by leuprolide acetate depot.
    Grau E; Torrecilla T; Real E; Sempere J
    Ann Pharmacother; 1994 Feb; 28(2):283-4. PubMed ID: 8173155
    [No Abstract]   [Full Text] [Related]  

  • 69. "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri.
    Sherwin BB; Tulandi T
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2545-9. PubMed ID: 8675575
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nd:YAG laser laparoscopic coagulation of symptomatic myomas.
    Goldfarb HA
    J Reprod Med; 1992 Jul; 37(7):636-8. PubMed ID: 1387912
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Recurrence of myomas after myomectomy in women pretreated with leuprolide acetate depot or placebo.
    Friedman AJ; Daly M; Juneau-Norcross M; Fine C; Rein MS
    Fertil Steril; 1992 Jul; 58(1):205-8. PubMed ID: 1624009
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The concentrations of collagen-associated amino acids are higher in GnRH agonist-treated uterine myomas.
    Rein MS; Barbieri RL; Welch W; Gleason RE; Caulfield JP; Friedman AJ
    Obstet Gynecol; 1993 Dec; 82(6):901-5. PubMed ID: 8233262
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [GnRH analogues and myomas: which strategy?].
    Poncelet C
    Gynecol Obstet Fertil; 2005 Dec; 33(12):1018. PubMed ID: 16316770
    [No Abstract]   [Full Text] [Related]  

  • 74. Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy.
    Mizutani T; Sugihara A; Honma H; Komura H; Nakamuro K; Terada N
    Gynecol Endocrinol; 2005 Feb; 20(2):80-3. PubMed ID: 15823826
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Short-term treatment with leuprolide acetate depot before surgical intervention for uterine leiomyomatosis].
    D'Anna R; Palmara V; Lo Re C; Scilipoti A; Leonardi I
    Minerva Ginecol; 1994 Jun; 46(6):343-6. PubMed ID: 7936386
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of chronic gonadotropin-releasing hormone analog (D-Trp-6) treatment on elevated and normal serum prolactin levels.
    Golan A; Bukovsky I; Weinraub Z; Ron-El R; Herman A; Raziel A; Caspi E
    Fertil Steril; 1989 Mar; 51(3):532-4. PubMed ID: 2522065
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Placebo effect--how powerful?
    Schmidt PJ; Rubinow DR
    Fertil Steril; 1993 May; 59(5):1144-5. PubMed ID: 8486192
    [No Abstract]   [Full Text] [Related]  

  • 78. Histopathologic findings in 107 uterine leiomyomas treated with leuprolide acetate compared with 126 controls.
    Sreenan JJ; Prayson RA; Biscotti CV; Thornton MH; Easley KA; Hart WR
    Am J Surg Pathol; 1996 Apr; 20(4):427-32. PubMed ID: 8604809
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Leuprolide acetate depot decreases the number of nucleolar organizer regions in uterine leiomyomata.
    Barbieri RL; Dilena M; Chumas J; Rein MS; Friedman AJ
    Fertil Steril; 1993 Sep; 60(3):569-70. PubMed ID: 8375543
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Calcium homeostasis, bone metabolism and safety aspects during long-term treatment with a GnRH agonist.
    Eckstein N; Foldes J; Feinstein Y; Vagman I; Eshel A; Steinberg R; Statter M; Limor R; Ayalon D
    Maturitas; 1992 Aug; 15(1):25-32. PubMed ID: 1388219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.